Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;15(6):271.
doi: 10.3892/mco.2021.2433. Epub 2021 Nov 1.

General insight into cancer: An overview of colorectal cancer (Review)

Affiliations
Review

General insight into cancer: An overview of colorectal cancer (Review)

Shiekhah Mohammad Alzahrani et al. Mol Clin Oncol. 2021 Dec.

Abstract

Cancer is currently among the leading causes of mortality globally. Colorectal cancer (CRC) ranks second among the most common types of cancer in terms of mortality worldwide. This type of cancer arises from mutations in the colonic and rectal epithelial tissues that target oncogenes, tumor suppressor genes and genes related to DNA repair mechanisms. The aim of the present review was to provide an explanation of CRC classification, which is carried out according to the histological subtype, location and molecular pathways implicated in its development. The pathogenic mechanisms implicated in CRC may involve one of three different molecular pathways: Chromosomal instability, microsatellite instability and cytosine preceding guanine island methylator phenotype. In addition, a variety of mutated genes associated with CRC, which affect certain signaling pathways, including DNA mismatch repair, cell cycle checkpoints and apoptotic pathways, were discussed. Moreover, a brief description of the risk factors and the symptoms associated with CRC was also provided. Finally, the treatment approaches to CRC were outlined.

Keywords: classifications; colorectal cancer; molecular pathways; risk factors and treatment; signaling pathways.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Center M, Siegel R, Jemal A. Global Cancer Facts and Figures 2010. American Cancer Society, Atlanta, GA, 2011.
    1. Omran AR. The epidemiologic transition: A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49:509–538. - PubMed
    1. Gersten O, Wilmoth JR. The cancer transition in Japan since 1951. Demogr Res. 2002;7:271–306.
    1. Idikio HA. Human cancer classification: A systems biology-based model integrating morphology, cancer stem cells, proteomics, and genomics. J Cancer. 2011;2:107–115. doi: 10.7150/jca.2.107. - DOI - PMC - PubMed

LinkOut - more resources